Nancy Lin
Nancy Lin
Dana-Farber Cancer Institute
Verified email at
Cited by
Cited by
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ...
Journal of Clinical Oncology 30 (4), 419, 2012
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
L Seymour, J Bogaerts, A Perrone, R Ford, LH Schwartz, S Mandrekar, ...
The Lancet Oncology 18 (3), e143-e152, 2017
4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634-1657, 2018
CNS metastases in breast cancer
NU Lin, JR Bellon, EP Winer
Journal of clinical oncology 22 (17), 3608-3617, 2004
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer
NU Lin, V Diéras, D Paul, D Lossignol, C Christodoulou, HJ Stemmler, ...
Clinical cancer research 15 (4), 1452-1459, 2009
Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer: high incidence of central nervous system metastases
NU Lin, E Claus, J Sohl, AR Razzak, A Arnaout, EP Winer
Cancer 113 (10), 2638-2645, 2008
Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets
PK Brastianos, SL Carter, S Santagata, DP Cahill, A Taylor-Weiner, ...
Cancer discovery 5 (11), 1164-1177, 2015
RECIST 1.1—Update and clarification: From the RECIST committee
LH Schwartz, S Litière, E De Vries, R Ford, S Gwyther, S Mandrekar, ...
European journal of cancer 62, 132-137, 2016
Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4.
E Neuman, MH Ladha, N Lin, TM Upton, SJ Miller, J DiRenzo, RG Pestell, ...
Molecular and cellular biology 17 (9), 5338-5347, 1997
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2–positive breast cancer
NU Lin, LA Carey, MC Liu, J Younger, SE Come, M Ewend, GJ Harris, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network
NU Lin, A Vanderplas, ME Hughes, RL Theriault, SB Edge, YN Wong, ...
Cancer 118 (22), 5463-5472, 2012
Response assessment criteria for brain metastases: proposal from the RANO group
NU Lin, EQ Lee, H Aoyama, IJ Barani, DP Barboriak, BG Baumert, ...
The lancet oncology 16 (6), e270-e278, 2015
Brain metastases: the HER2 paradigm
NU Lin, EP Winer
Clinical Cancer Research 13 (6), 1648-1655, 2007
Systemic therapy for patients with advanced human epidermal growth factor receptor 2–positive breast cancer: American Society of Clinical Oncology clinical practice guideline
SH Giordano, S Temin, JJ Kirshner, S Chandarlapaty, JR Crews, ...
Journal of clinical oncology 32 (19), 2078, 2014
Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer
N Tung, NU Lin, J Kidd, BA Allen, N Singh, RJ Wenstrup, AR Hartman, ...
Journal of Clinical Oncology 34 (13), 1460, 2016
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ...
International Journal of Radiation Oncology* Biology* Physics 82 (5), 2111-2117, 2012
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
VA Adalsteinsson, G Ha, SS Freeman, AD Choudhury, DG Stover, ...
Nature communications 8 (1), 1-13, 2017
CNS metastases in breast cancer: old challenge, new frontiers
NU Lin, L Amiri-Kordestani, D Palmieri, DJ Liewehr, PS Steeg
Clinical Cancer Research 19 (23), 6404-6418, 2013
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
RK Murthy, S Loi, A Okines, E Paplomata, E Hamilton, SA Hurvitz, NU Lin, ...
New England Journal of Medicine 382 (7), 597-609, 2020
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
S Santagata, R Hu, NU Lin, ML Mendillo, LC Collins, SE Hankinson, ...
Proceedings of the National Academy of Sciences 108 (45), 18378-18383, 2011
The system can't perform the operation now. Try again later.
Articles 1–20